About Technology Issues FAQ

Links

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.